Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome

Omri Teltsh; Angel Porgador; Eitan Rubin

doi:10.18632/oncotarget.5052

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome

Omri Teltsh, Angel Porgador and Eitan Rubin _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:33191-33205. https://doi.org/10.18632/oncotarget.5052

Metrics: PDF 2010 views | HTML 1806 views | ?

Abstract

Omri Teltsh1, Angel Porgador1,*, Eitan Rubin1,*

1The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, Israel

*These authors have contributed equally to this work

Correspondence to:

Eitan Rubin, e-mail: [email protected]

Angel Porgador, e-mail: [email protected]

Keywords: cancer microenvironment, immunome, precision cancer medicine, RNAseq, TCGA

Received: June 07, 2015 Accepted: August 28, 2015 Published: September 07, 2015

ABSTRACT

Investigating the expression of genes in cancer-associated immune cells (immunome) is imperative for prognosis prediction. However, evaluating the expression of immune-associated genes within cancer biopsy is subject to significant inconsistencies related to the sampling methodology. Here, we present immFocus, a method for extracting immune signals from total RNA sequencing of tumor biopsies, intended for immunity depiction and prognosis evaluation. It is based on reducing the variation which biopsy preparation adds to the apparent expression levels of immune genes. We employed immFocus to normalize gene expression with an immune index using data obtained from renal clear cell carcinoma biopsies. Genes that became less variable due to normalization were found to be preferentially immune-related. Moreover, immune-related genes tended to become more prognostic due to the normalization. These results demonstrate, for the first time, that whole transcriptome sequencing can be used for interrogation of a cancer immunome and for advancing immune-based prognosis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5052

Publication Alerts

Research Papers:

Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome

Abstract